Basics Ventyx Biosciences, Inc. IPO Date: October 21, 2021 Sector: Healthcare Industry: Biotech Market Cap: $622.25M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.89% Avg Daily Range (30 D): $0.36 | 4.42% Avg Daily Range (90 D): $0.20 | 4.15% Institutional Daily Volume Avg Daily Volume: 1.2M Avg Daily Volume (30 D): 5.79M Avg Daily Volume (90 D): 2.72M Trade Size Avg Trade Size (Sh.): 126 Avg Trade Size (Sh.) (30 D): 112 Avg Trade Size (Sh.) (90 D): 118 Institutional Trades Total Inst.Trades: 1,177 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $.95M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 134.29K     News Oct 26, 2025 @ 10:33 PM BioAge Labs Stock Just Soared. Does It Have More F... Source: Cory Renauer Sep 6, 2024 @ 12:00 PM Ventyx Biosciences Announces Initiation of Dosing ... Source: Ventyx Biosciences, Inc. May 16, 2024 @ 8:05 PM Ventyx Biosciences to Participate in Three Upcomin... Source: Ventyx Biosciences, Inc. May 2, 2024 @ 8:05 PM Ventyx Biosciences to Report First Quarter 2024 Fi... Source: Ventyx Biosciences, Inc. Apr 30, 2024 @ 4:00 PM What Makes Ventyx Biosciences (VTYX) a New Buy Sto... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.49 $-.32 $-.38 Diluted EPS $-1.49 $-.32 $-.38 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -106.61M $ -22.83M $ -26.99M Operating Income / Loss $ -116.72M $ -24.87M $ -29.33M Cost of Revenue $ $ $ Net Cash Flow $ -29.85M $ -.25M $ 4.68M PE Ratio